Shorter survival time seen in young prostate cancer patients

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 9
Volume 18
Issue 9

Young men with advanced forms of prostate cancer do not live as long as older men with similar forms of the disease, according to research conducted at the University of Washington in Seattle.

Young men with advanced forms of prostate cancer do not live as long as older men with similar forms of the disease, according to research conducted at the University of Washington in Seattle.

Daniel Lin, MD, and colleagues, mined the SEER database to identify 318,774 men diagnosed with prostate cancer between 1988 and 2003. Among men with advanced prostate cancers, the youngest men (ages 35 to 44) had a particularly poor prognosis, compared with older men. The younger men were more likely to die from cancer, or another cause, sooner than older men with similar forms of cancer (Cancer online, May 22, 2009).

The researchers suspect young men with advanced prostate cancer may have biologically more aggressive forms of the disease.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Machine learning-based approaches may play a role in further understanding of how somatic alterations influence responses or resistance to therapy.
Data from a first-in-disease trial assessing a personalized cancer vaccine in RCC require validation at a larger level, according to David Braun, MD, PhD.
Experts highlight methods for optimally treating patients with genitourinary cancers harboring variant histologies at World GU 2025.